C
Hemab Therapeutics Holdings, Inc. Common Stock
COAG · NASDAQ · Healthcare · 2.6B
Closing price
$31.62
+2.36% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-12.1×
Free cash flow yieldFCF yield
-6.6%
Return on equityROE
36.2%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.